Literature DB >> 8517708

Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants.

N B Murphy1, A M Muthiani, A S Peregrine.   

Abstract

We determined the level of susceptibility of Trypanosoma brucei brucei to the aminoglycoside G418 in vivo and demonstrated that it is possible to select for G418-resistant transfected T. brucei brucei bloodstream parasites in a mouse host by inoculating the drug intraperitoneally at doses between 40 and 80 mg/kg of body weight daily for 3 days. The ability to select for transfectants in vivo offers new possibilities for studies on genetic recombination in these parasites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517708      PMCID: PMC187924          DOI: 10.1128/AAC.37.5.1167

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  The cultivation of Trypanosoma congolense in vitro.

Authors:  E J TOBIE
Journal:  J Parasitol       Date:  1958-04       Impact factor: 1.276

2.  High-efficiency clonal growth of bloodstream- and insect-form Trypanosoma brucei on agarose plates.

Authors:  V B Carruthers; G A Cross
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

3.  Stable integrative transformation of Trypanosoma brucei that occurs exclusively by homologous recombination.

Authors:  J Eid; B Sollner-Webb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

4.  Homologous recombination and stable transfection in the parasitic protozoan Trypanosoma brucei.

Authors:  M G Lee; L H Van der Ploeg
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

5.  Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers.

Authors:  H Hirumi; K Hirumi
Journal:  J Parasitol       Date:  1989-12       Impact factor: 1.276

6.  Three small RNAs within the 10 kb trypanosome rRNA transcription unit are analogous to domain VII of other eukaryotic 28S rRNAs.

Authors:  T C White; G Rudenko; P Borst
Journal:  Nucleic Acids Res       Date:  1986-12-09       Impact factor: 16.971

7.  The epidemiology of Trypanosoma rhodesiense sleeping sickness in Alego location, Central Nyanza, Kenya. I. Evidence that cattle may act as reservoir hosts of trypanosomes infective to man.

Authors:  R J Onyango; K Van Hoeve; P De Raadt
Journal:  Trans R Soc Trop Med Hyg       Date:  1966       Impact factor: 2.184

8.  Disulfide bond involvement in the maintenance of the cryptic nature of the cross-reacting determinant of metacyclic forms of Trypanosoma congolense.

Authors:  W R Fish; C W Muriuki; A M Muthiani; D J Grab; J D Lonsdale-Eccles
Journal:  Biochemistry       Date:  1989-06-27       Impact factor: 3.162

9.  Targeted insertion of the neomycin phosphotransferase gene into the tubulin gene cluster of Trypanosoma brucei.

Authors:  A L ten Asbroek; M Ouellette; P Borst
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

10.  The hygromycin B-resistance-encoding gene as a selectable marker for stable transformation of Trypanosoma brucei.

Authors:  M G Lee; L H van der Ploeg
Journal:  Gene       Date:  1991-09-15       Impact factor: 3.688

View more
  3 in total

1.  DNA rearrangements associated with multiple consecutive directed antigenic switches in Trypanosoma brucei.

Authors:  M Navarro; G A Cross
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

2.  Using T. brucei as a biological epitope-display platform to elicit specific antibody responses.

Authors:  Pete Stavropoulos; F Nina Papavasiliou
Journal:  J Immunol Methods       Date:  2010-08-26       Impact factor: 2.303

3.  Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein.

Authors:  Solange dos Santos Costa; Marjorie de Assis Golim; Bartira Rossi-Bergmann; Fabio Trindade Maranhão Costa; Selma Giorgio
Journal:  Korean J Parasitol       Date:  2011-12-16       Impact factor: 1.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.